[c09aa8]: / clusters / 9knumclustersv2 / clust_886.txt

Download this file

51 lines (50 with data), 4.1 kB

 1
 2
 3
 4
 5
 6
 7
 8
 9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
Magnesium >= LLN
Magnesium >= LLN within days before the first dose of cabozantinib
Magnesium >= LLN
Documented within days of registration: Magnesium: >= . mmol/L
Serum potassium and magnesium greater than the institutional LLN.
Magnesium within normal range (supplementation is allowed)
Magnesium WNL
Magnesium > . and < . mg/dL.
Magnesium WNL
Magnesium > LLN or correctable with supplements prior to first dose of study medication
Serum magnesium >= ILLN
Magnesium >= . mg/dL
Serum magnesium >= LLN
Magnesium before the first dose of ceritinib
Serum magnesium >= LLN
Magnesium level between .-. mg
Normal magnesium (can be on oral supplementation)
Magnesium (triplet combination only) >= . mg/dL
Magnesium >= LLN =< days prior to registration\r\n* NOTE: Supplementation may be given before the first dose of study medication
Within days prior to registration: Magnesium within institutions normal range
The following assessments are required within days prior to registration: sodium (Na), potassium (K), chlorine (Cl), glucose, calcium (Ca), magnesium (Mg), and albumin; note: patients with an initial magnesium < . mmol/L (. mg/dl) may receive corrective magnesium supplementation but should continue to receive either prophylactic weekly infusion of magnesium and/or oral magnesium supplementation (e.g., magnesium oxide) at the investigators discretion
The following assessments are required within days prior to registration: sodium (Na), potassium (K), chloride (Cl), glucose, calcium (Ca), magnesium (Mg), and albumin; Note: patients with an initial magnesium < . mmol/L (. mg/dl) may receive corrective magnesium supplementation but should continue to receive either prophylactic weekly infusion of magnesium and/or oral magnesium supplementation (e.g., magnesium oxide) at the investigators discretion
Serum magnesium within normal limits
Serum magnesium within normal range (patients may receive magnesium supplementation to achieve normal levels)
Performed within days of patient registration: Serum magnesium > . mg/dL(can be achieved with replacement)\r\n* NOTE: The package insert for the study drug, romidepsin, does not require subject blood levels of potassium (K) and magnesium (Mg) to be at a certain level; therefore in this study, we will require K > . and Mg > . for eligibility, but for the rest of the treatment parameters during the course of the study we will require these electrolytes to be within normal range (WNL)
Magnesium >= LLN
The following assessments are required within weeks prior to the start of registration: sodium (Na), potassium (K), chloride (Cl), glucose, calcium (Ca), magnesium (Mg), and albumin; note: patients with an initial magnesium < . mmol/L (. mg/dl) may receive corrective magnesium supplementation but should continue to receive either prophylactic weekly infusion of magnesium and/or oral magnesium supplementation (e.g., magnesium oxide) at the investigators discretion
Serum magnesium levels outside the laboratorys reference range
Magnesium . . mg/dL
Serum magnesium ? Institutional LLN
Magnesium
Serum magnesium >= LLN
Magnesium >= LLN
Serum magnesium >= LLN
Magnesium (. - ULN)
Serum magnesium greater than or equal to . mg/dL
Subjects with initial magnesium < . mmol/liter (. mg/deciliter) may receive corrective magnesium supplementation but should continue to receive either prophylactic weekly infusion of magnesium and/or oral magnesium supplementation
Serum magnesium >= LLN
Serum magnesium > .; electrolyte repletion is allowed to reach these values
Magnesium less than . milligram per deciliter (mg/dL)
Serum magnesium >= LLN
Serum magnesium >= LLN
Serum magnesium must be within institutional normal limits
Serum magnesium greater than the LLN and < . mg/dL or . mmol/L
Normal serum electrolytes, magnesium and phosphorus on the day of therapy; correction of abnormalities is permitted
Magnesium within normal limits (supplementation allowed)
Magnesium >= . mg/dL
Serum magnesium >= . mg/dL
Participants with a calcium/magnesium intake ratio > .
Magnesium below the normal range despite supplementation, or above the CTCAE grade upper limit